UPM’s 2025 Annual Report highlights resilient cash flow and strategic progress despite a 25% drop in comparable EBIT to €921 million. The company advanced major portfolio changes, ramped up its Leuna biochemicals refinery, proposed a graphic paper joint venture with Sappi, and maintained a strong balance sheet while continuing to deliver high sustainability performance.
Proofed (Human)
Listen to This Article
Loading...
Login
New User? Signup
Reset Password
Signup
Existing User? Login here
Login here
Reset Password
Please enter your registered email address. You will recieve a link to reset your password via email.
New User? Signup
Currency Exchange Graph